|
Status |
Public on Mar 28, 2017 |
Title |
METS (metastasis-derived DLD1 derivative) colorectal cancer cell line, replicat 2 |
Sample type |
RNA |
|
|
Source name |
colorectal cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
parental cell type: colorectal cancer cell line DLD1 cell characteristics: epithelial, derived from xenograft lung metastasis
|
Treatment protocol |
no treatment
|
Growth protocol |
Colorectal cancer cell line DLD1 and its derivatives were maintained in McCoy`s 5A Medium (Invitrogen) containing 10% fetal bovine serum (FBS, Invitrogen), 100 units/ml penicillin and 0.1 mg/ml streptomycin.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA from cell lines was isolated using the miRNeasy Kit (Qiagen).
|
Label |
Cy3
|
Label protocol |
Standard Agilent Protocol for Cy3 labeling
|
|
|
Hybridization protocol |
Standard Agilent Protocol
|
Scan protocol |
Standard Agilent Protocol
|
Description |
METS (metastasis-derived DLD1 derivative) colorectal cancer cell line
|
Data processing |
Quantile normalization was performed using the preprocessCore package with R version 3.2.0
|
|
|
Submission date |
Aug 16, 2016 |
Last update date |
Mar 29, 2017 |
Contact name |
Matjaz Rokavec |
E-mail(s) |
[email protected]
|
Organization name |
Ludwig-Maximilians-University Munich
|
Department |
Institute of Pathology
|
Lab |
Hermeking
|
Street address |
Thalkirchner Str. 36
|
City |
Munich |
ZIP/Postal code |
80337 |
Country |
Germany |
|
|
Platform ID |
GPL21576 |
Series (2) |
GSE85687 |
microRNA profiling of four DLD1 colorectal cancer cell derivatives that recapitulate EMT/MET transitions during metastasis. |
GSE85688 |
Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis. |
|